This content is not available in your region

Pfizer third-quarter profit jumps 45 percent

Access to the comments Comments
Pfizer third-quarter profit jumps 45 percent
FILE PHOTO: A man walks past Pfizer's world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo   -   Copyright  Andrew Kelly(Reuters)
Text size Aa Aa

(Reuters) – U.S. drugmaker Pfizer Inc’s <PFE.N> third-quarter profit rose nearly 45 percent, driven by lower tax rates and higher sales of breast cancer drug Ibrance and pneumonia vaccine Prevnar.

The company said on Tuesday net income rose to $4.11 billion (3.22 billion pounds) or 69 cents per share in the three months ended Sept. 30, from $2.84 billion or 47 cents per share a year earlier.

Revenue climbed to $13.30 billion from $13.17 billion.

(Reporting by Tamara Mathias in Bengaluru; Editing by Sai Sachin Ravikumar)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.